SCHEMBL30130292

SCHEMBL30130292

COc1ccc(Cn2c(=O)c3c(n4ncnc24)CCNC3)c(OC)c1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PDE1B Q01064 4/20 0.43
▸ SLC33A1 O00400 1/20 0.42
▸ PDE2A O00408 1/20 0.40
▸ TSHR P16473 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ HTT P42858 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ P2RX3 P56373 1/20 0.39
▸ KDM4E B2RXH2 3/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ GNRHR P30968 1/20 0.36
▸ EGLN1 Q9GZT9 2/20 0.36
▸ GAA P10253 2/20 0.35
▸ PTGS1 P23219 1/20 0.35
▸ PTGS2 P35354 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.34
▸ APLNR P35414 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24914494 0.84 ALDH1A1 (0.39) PDE1BTSHRP2RX3KDM4EMAPK1
SCHEMBL30130296 0.84 ALDH1A1 (0.39) PDE1BTSHRP2RX3KDM4EMAPK1
SCHEMBL30130239 0.83 CLPP (0.49) TSHRP2RX3KDM4EMAPK1ALDH1A1
SCHEMBL24914779 0.83 CLPP (0.49) TSHRP2RX3KDM4EMAPK1ALDH1A1
SCHEMBL24914516 0.68 CLPP (0.65) PDE1B
SCHEMBL4154483 0.62 APLNR (0.54) TSHRKDM4EMAPK1ALDH1A1GAA
SCHEMBL22715321 0.62 CYP1A2 (0.48) TSHRLMNAKDM4EMAPK1ALDH1A1
SCHEMBL23120457 0.62 ALDH1A1 (0.49) TSHRLMNAKDM4EMAPK1ALDH1A1
SCHEMBL392360 0.62 CYP1A2 (0.62) TSHRLMNASMN1; SMN2KDM4EMAPK1
SCHEMBL24914799 0.62 CLPP (0.63) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240327408-A1 COMPOUNDS CONTAINING TETRAHYDRONAPHTHYRIDINONE OR TETRAHYDROPYRIDOPYRIMIDINONE SKELETON, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF CHINA PHARMACEUTICAL UNIVERSITY (CN) 2024-10-03 — — US disclosed
CN-115611896-A Compound containing tetralone or tetrahydropyridopyrimidone skeleton and preparation method and pharmaceutical application thereof 中国药科大学 2023-01-17 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240327408-A1 COMPOUNDS CONTAINING TETRAHYDRONAPHTHYRIDINONE OR TETRAHYDROPYRIDOPYRIMIDINONE SKELETON, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF PRCP, TMPRSS15, WEE1 PDE1B 1214/4885SLC33A1 2845/4885PDE2A 4424/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback